BsAb Armed-T Therapy Platform

Revolutionizing T Cell Cancer Treatment

CytoArm’s innovative BsAb Armed-T therapy platform utilizes non-viral bi-functional antibodies (BsAb) to empower T cells in targeting tumor cells effectively. This pioneering approach enables adaptable cancer treatments across various oncological conditions, potentially addressing limitless diseases

CytoArm’s Non-Viral BsAb Armed-T therapy is a platform that Adaptable and Targeted Cancer Treatments covering over 50 diseases